The Niche
Trusted stem cell blog & resources
- Website
- ipscell.com · all feeds from this site
- Feed URL
https://ipscell.com/feed/
Read it in your FeedListing reader
Or add to: Feedly Inoreader Raw feed
Latest posts
-
2 new FDA warning letters with an odd one for totipotent stem cells & Laennec
I check the FDA warning letters database about twice a month for new biologics warnings. The FDA posts new letters weekly. Sometimes weeks or months go by with no new warnings from the CBER branch. 2026 has brought a steady stream of cell therapy-related warnings. Two notable,…
-
Weekly reads: ER-100 trial update, ND AG stem cell alert, autoimmune CAR-T hurdles, AI effects on biologists, No on Prop 38
David Sinclair’s firm Life Biosciences recently launched a first-of-its-kind in vivo reprogramming trial called ER-100. I wrote about how the odds were against this trial succeeding but hoped I was wrong to be skeptical. The idea is to use a pulse of OCT4, SOX2, and KLF4 (OSK)…
-
Weekly reads: Trump’s Granddaughter gets MUSE cell injection, fibroblast plasticity, unusual FDA warning
I just wrote about the complicated MUSE cell situation in the US. Marketing of these unapproved cells is all over the place now. It’s so widespread that celebrities and other well-known folks are trying MUSE cells. Trump’s granddaughter’s MUSE cell procedure For instance, now we…
-
New class action suit vs QC Kinetix: tie to Florida stem cell law, potential impact on field
I wrote before about a proposed class action suit against QC Kinetix, which was settled. That post also included my broader views on QC back when I wrote it. Now there is a new suit, which could be significant for the field in several ways. QC Kinetix is a large network of…
-
Weekly reads: G&D trio, Regenative Labs sues FDA, OCT4 sub, SpudCells, SRSF1 as an anti-aging factor?
Early on in my career as a graduate student in Mark Kamps’ lab, we had some go-to journals like G&D and MCB. Such journals often published papers in our areas of interest on Hox, Meis, and Pbx proteins as well as pre-B cell ALL. We published there too. For those not familiar,…
-
America’s growing Muse cell mess: Dezawa Muse cells, “counterfeits”, & FDA compliance questions
Muse cells have jumped back onto my radar screen in the past year, including one specific type called Dezawa Muse cells. They are purported adult pluripotent stem cells. The combination of “adult” and “pluripotent” never made sense to me, but these cells have their fans. What’s…
-
Weekly reads: stem cell and peptides via RFK Jr., Urnov vs. Tie exchange fire, med centers cash in on longevity, the end for Caribou
What’s the stem cell and peptides connection? The first time I heard of “peptides” (meaning the unproven wellness ones) it was from a fan of unproven stem cell clinics. It was an aha moment of connection. More recently, dubious peptides and stem cells are often marketed by the…
-
Pop peptide politics: RFK Jr. reportedly will force quick access before required rulemaking
How far will RFK Jr. go to create a new golden age of profit for peptide firms? We’re seeing the answer now. The Washington Post just reported that the administration has plans to allow compounding of a set of popular but unproven peptides. I call these “pop peptides” to reflect…
-
Weekly reads: AI grant review, sham orgs trick academics, Origin Genomics, CRISPR babies
It’s been a wild few weeks for AI in science with the latest revelation that a key UK funder did AI grant review. Let’s start there with our weekly discussion. I should note that 13 years ago I drew a cartoon imagining something like this with robots reviewing grants. Mice with…
-
Wild Scott Carney stem cell ‘buffet’ video: Adeel Kahn, Kardashians, Muse cells, Liveyon, Platinum Biologics, & more
I’ve written before about Adeel Khan, who reportedly gave some kind of Muse cells to the Kardashian sisters. Regular readers of The Niche might recall that I’m skeptical about Muse cells. I’ll have a lot more on these cells over the next few weeks. Today I’m focusing on a new…
-
Weekly reads: $100B NIH budget dream, Sholto David on YouTube, Jun Takahashi award, Muse cell developments
What should the NIH budget be these days? Certainly higher than it is, but what would the ideal level be? One of my weekly reads is a proposal for $100B in NIH funding. All things considered, that seems reasonable to me. NIH is a massive engine of innovation for our country that…